What the company does
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat major depressive disorder and schizophrenia; Vyepti for migraine prevention; and Cipralex/Lexapro for depression. It also provides Northera for symptomatic neurogenic orthostatic hypotension; Onfi for epilepsy; Sabril for refractory complex partial seizures and infantile spasms; Ebixa for dementia, Azilect for Parkinson's disease; Xenazine for chorea; Deanxit for …
What the weekly tape is saying
LUNA closed the latest completed week at 4.89 EUR. The 4-week return is 1.2% and the 12-week return is 10.4%. Trend Signal is active, Market Dynamics is 1.14. Setup signature: Leadership continuation with a 75/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 4.09 EUR
- Vs Trend Line
- 19.6%
- Fair Value
- 2.88 EUR
- Vs Fair Value
- 69.9%
- 52W High
- 5.05 EUR
- 52W Low
- 2.88 EUR
- Drawdown
- -3.2%
- Range Position
- 92.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 13 weeks
- 52W Active Weeks
- 50
- 52W Active Breadth
- 96.2%
- Sector Scope
- AT Healthcare
- Sector Rank
- 84 of 112
- Sector Percentile
- 25.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 64 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 16
- 4W Rank
- 6 of 16
- Avg 1W
- -0.1%
- Avg 4W
- 0.6%
- Trend Breadth
- 56.3%
- Positive RS
- 25.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.14
- 4W MD Change
- -0.3%
- Relative Strength
- 7.42
- 4W RS Change
- -48.2%
- Expectation
- Positive
- Probability
- 55.58%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.1K
- 13W Average
- 517
- 52W Average
- 378
- Vs 13W
- 2.2x
- Vs 52W
- 3.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.3%
- 52W Volatility
- 5.4%
- Upside Weeks
- 30
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 3.7% / -2.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- EUR
- Market Cap
- 5.3B
Opportunity signals
- Trend Signal is active with a 13-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Recent volatility is running well above the one-year baseline.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 4.89 EUR | -3.0% | 4.09 EUR | 2.88 EUR | 1.14 | 7.42 | 1.1K | On |
| 5 Jun 2026 | 5.04 EUR | 2.5% | 4.04 EUR | 2.86 EUR | 1.21 | 14.03 | 3.3K | On |
| 29 May 2026 | 4.92 EUR | 2.8% | 3.99 EUR | 2.84 EUR | 1.13 | 10.33 | 0 | On |
| 22 May 2026 | 4.78 EUR | -1.0% | 3.95 EUR | 2.83 EUR | 1.12 | 10.56 | 0 | On |
| 15 May 2026 | 4.83 EUR | 2.7% | 3.91 EUR | 2.81 EUR | 1.14 | 14.32 | 2.3K | On |
| 8 May 2026 | 4.71 EUR | -0.7% | 3.87 EUR | 2.79 EUR | 1.09 | 11.31 | 0 | On |
| 1 May 2026 | 4.74 EUR | -0.3% | 3.83 EUR | 2.78 EUR | 1.12 | 14.43 | 0 | On |
| 24 Apr 2026 | 4.75 EUR | 0.5% | 3.79 EUR | 2.76 EUR | 1.17 | 16.00 | 0 | On |
| 17 Apr 2026 | 4.73 EUR | 2.8% | 3.75 EUR | 2.74 EUR | 1.09 | 12.02 | 0 | On |
| 10 Apr 2026 | 4.60 EUR | 0.9% | 3.72 EUR | 2.73 EUR | 1.02 | 12.17 | 0 | On |
| 3 Apr 2026 | 4.56 EUR | 6.3% | 3.68 EUR | 2.71 EUR | 0.46 | 18.91 | 0 | On |
| 27 Mar 2026 | 4.29 EUR | -3.2% | 3.64 EUR | 2.69 EUR | -0.11 | 16.30 | 0 | On |
| 20 Mar 2026 | 4.43 EUR | 30.4% | 3.61 EUR | 2.68 EUR | -0.52 | 22.14 | 0 | On |
| 13 Mar 2026 | 3.40 EUR | -0.7% | 3.57 EUR | 2.66 EUR | -0.86 | -6.95 | 0 | Off |